-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C2qow3V1hTmKeU3BIEsWdtYQDTuuvzH9QdKAVN/GXwl8IjMXG+VuFUluNiO1iaHH PRrCu7AtKnPhLGlRoVVDPQ== 0000919574-98-000512.txt : 19980428 0000919574-98-000512.hdr.sgml : 19980428 ACCESSION NUMBER: 0000919574-98-000512 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980415 FILED AS OF DATE: 19980427 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN SPECIALTY THERAPEUTICS INC CENTRAL INDEX KEY: 0001049711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330779207 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-23641 FILM NUMBER: 98601969 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142466912 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 COMPANY DATA: COMPANY CONFORMED NAME: CONSTABLE LOURDE JOHN CENTRAL INDEX KEY: 0001060522 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 5 RADNOR CORP CENTER STREET 2: 100 MATSONFORD ROAD SUITE 520 CITY: RADNOR STATE: PA ZIP: 19087 BUSINESS PHONE: 6109640750 MAIL ADDRESS: STREET 1: 5 RADNOR CORP CENTER STREET 2: 100 MATSONFORD ROAD SUITE 520 CITY: RADNOR STATE: PA ZIP: 19087 3 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 1. Name and Address of Reporting Person Lourde John Constable 5 Radnor Corp. Center 100 Matsonford Rd. Suite #520 Radnor, Pennsylvania 19087 2. Date of Event Requiring Statement (Month/Day/Year) April 15, 1998 3. IRS Number of Reporting Person (Voluntary) 4. Issuer Name and Ticker or Trading Symbol Allergan Specialty Therapeutics, Inc. (ASTI) 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other (specify below) 6. If Amendment, Date of Original (Month/Day/Year) 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person Table I -- Non-Derivative Securities Beneficially Owned 1. Title of Security 2. Amount of 3. Ownership 4. Nature of Indirect Securities Form: Beneficial Ownership Beneficially Direct(D) or Owned Indirect(I) Common Stock 426,000* (I) General Partner or Investment Manager Table II -- Derivative Securities Beneficially Owned 1.Title of 2.Date Exer- 3.Title and Amount 4. Conver- 5. Ownership 6. Nature of Derivative cisable and of Securities sion or Form of Indirect Security Expiration Underlying Exercise Derivative Beneficial Date Derivative Security Price of Security: Ownership (Month/Day/ --------------- Deri- Direct(D) or Year) Title Amount or vative Indirect (I) --------------- Number of Security Date Expira- Shares Exer- tion cisable Date
Explanation of Responses: * The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. SIGNATURE OF REPORTING PERSON Lourde John Constable /s/ Lourde John Constable ___________________________ DATE: April 27, 1998 2 02414001.AA1
-----END PRIVACY-ENHANCED MESSAGE-----